A new therapy combining SBRT and immunotherapy shows promise for TNBC patients.
― 6 min read
Caigang Liu
Study shows potential of combining radiotherapy with dalpiciclib and exemestane.
― 5 min read
Cutting edge science explained simply
A new therapy combining SBRT and immunotherapy shows promise for TNBC patients.
― 6 min read
Study shows potential of combining radiotherapy with dalpiciclib and exemestane.
― 5 min read